0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2007;297(20):2167. doi:10.1001/jama.297.20.2167.
Text Size: A A A
Published online

MALARIA

A JAMA THEME ISSUE

Edited by Gianna Zuccotti, MD, MPH, and Catherine D. DeAngelis, MD, MPH

TREATMENT OF

When Plasmodium falciparum and Plasmodium vivax coexist and species-specific malaria diagnosis is difficult, treatment that is efficacious against both species is desirable. Leslie and colleagues conducted a randomized trial testing the relative efficacy and safety of 2 antifolate therapies vs chloroquine for P vivax malaria in Pakistan and Afghanistan. They found that although chloroquine is the drug of choice, all 3 therapies effectively cleared parasites by day 14 and were well tolerated.

COMBINATION ANTIMALARIAL THERAPY IN CHILDREN

In a randomized trial involving Ugandan children with first-episode uncomplicated falciparum malaria, Dorsey and colleagues compared the efficacy and safety of 3 combination regimens and found that artemether-lumefantrine was associated with the lowest 28-day risk of parasitological failure.

HEMOGLOBIN VARIANTS AND SIGNS OF SEVERE MALARIA

In a case-control study involving children with severe falciparum malaria, May and colleagues found that the hemoglobin S carrier state was negatively associated with all major manifestations of severe disease, whereas the hemoglobin C and α+-thalassemia carrier states were negatively associated with cerebral malaria and severe anemia, respectively.

DIAGNOSTIC TESTING AND MALARIA TREATMENT

Among patients with fever seen at Zambian health facilities having either microscopy or malaria rapid diagnostic testing capabilities, Hamer and colleagues found that only 27.8% of patients had diagnostic testing performed, and patients with negative test results were often prescribed antimalarial agents.

NEUROLOGICAL FEATURES OF MALARIA IN CHILDREN

Idro and colleagues reviewed patient records for Kenyan children younger than 14 years who were admitted to the hospital with acute falciparum malaria and found that almost half had neurological involvement, most often seizures or impaired consciousness or coma, and with an associated higher risk of mortality or neurological sequelae.

INSECTICIDE-TREATED NETS IN AFRICA

In an analysis of survey data reflecting the availability of insecticide-treated nets (ITNs) in 43 African countries, Miller and colleagues estimated that 16.7 million ITNs were available in households at risk in 2003. They calculate that between 130 million and 264 million ITNs will be required in 2007 to reach an 80% coverage target for young children and pregnant women in these countries.

CLINICIAN'S CORNER

Griffith and colleagues report results of a systematic literature review of diagnostic modalities and available pharmacotherapies to guide the rapid diagnosis and appropriate treatment of malaria in patients in the United States.

A PIECE OF MY MIND

“Fighting diseases such as malaria in Africa requires opening the space for dialogue, not just at the political and governmental levels, but within communities.” From “Don't Sleep With Your Chickens.”

MEDICAL NEWS & PERSPECTIVES

Malaria researchers are seeking better drugs and ways to control the parasite's mosquito vectors.

CHEMOPROPHYLAXIS FOR TRAVELERS

Controversies and misconceptions reflected in national chemoprophylaxis guidelines.

DRUG RESISTANCE

Make global surveillance to detect artemisin resistance a priority.

GLOBAL MALARIA CONTROL

Strong leadership, effective management, and sufficient funding could make global malaria control a reality.

MALARIA 2007

The issue editors discuss progress and challenges in malaria control.

LITERATIM

Epidemics revisited for today's readers.

JAMA PATIENT PAGE

For your patients: Information about malaria.

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.